AU783952B2 - Nasal calcitonin formulations - Google Patents

Nasal calcitonin formulations Download PDF

Info

Publication number
AU783952B2
AU783952B2 AU36604/01A AU3660401A AU783952B2 AU 783952 B2 AU783952 B2 AU 783952B2 AU 36604/01 A AU36604/01 A AU 36604/01A AU 3660401 A AU3660401 A AU 3660401A AU 783952 B2 AU783952 B2 AU 783952B2
Authority
AU
Australia
Prior art keywords
calcitonin
composition
pharmaceutical composition
citric acid
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU36604/01A
Other languages
English (en)
Other versions
AU3660401A (en
Inventor
William Stern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unigene Laboratories Inc
Original Assignee
Unigene Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22659737&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU783952(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Unigene Laboratories Inc filed Critical Unigene Laboratories Inc
Publication of AU3660401A publication Critical patent/AU3660401A/en
Application granted granted Critical
Publication of AU783952B2 publication Critical patent/AU783952B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU36604/01A 2000-02-04 2001-01-31 Nasal calcitonin formulations Ceased AU783952B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18024100P 2000-02-04 2000-02-04
US60/180241 2000-02-04
PCT/US2001/003212 WO2001056594A1 (en) 2000-02-04 2001-01-31 Nasal calcitonin formulations

Publications (2)

Publication Number Publication Date
AU3660401A AU3660401A (en) 2001-08-14
AU783952B2 true AU783952B2 (en) 2006-01-05

Family

ID=22659737

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36604/01A Ceased AU783952B2 (en) 2000-02-04 2001-01-31 Nasal calcitonin formulations

Country Status (6)

Country Link
US (3) US6440392B1 (de)
EP (1) EP1251867A4 (de)
CN (1) CN1183965C (de)
AU (1) AU783952B2 (de)
CA (1) CA2399505C (de)
WO (1) WO2001056594A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001056594A1 (en) 2000-02-04 2001-08-09 Unigene Laboratories, Inc. Nasal calcitonin formulations
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
EP1631308B1 (de) * 2003-05-30 2013-07-31 Amylin Pharmaceuticals, LLC Neue verfahren und zusammensetzungen für die verbesserte transmukosale abgabe von peptiden und proteinen
CN1546169A (zh) * 2003-12-16 2004-11-17 上海医药工业研究院 一种降钙素经鼻干粉吸入剂及制备方法
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20090069226A1 (en) * 2004-05-28 2009-03-12 Amylin Pharmaceuticals, Inc. Transmucosal delivery of peptides and proteins
US8377863B2 (en) 2007-05-29 2013-02-19 Unigene Laboratories Inc. Peptide pharmaceutical for oral delivery
CN101549149B (zh) * 2008-09-17 2011-12-28 北京双鹭药业股份有限公司 一种新的降钙素的水溶液鼻用喷雾制剂
US20100256060A1 (en) * 2009-04-02 2010-10-07 Unigene Laboratories Inc. Peptide pharmaceuticals for nasal delivery
EP2964193B1 (de) 2013-03-05 2019-12-11 Enteris BioPharma, Inc. Arzneimittel zur oralen verabreichung
KR102294577B1 (ko) 2015-01-12 2021-08-26 엔터리스 바이오파마, 인크. 고체 경구 제형
CN108969754B (zh) * 2018-09-04 2019-06-21 深圳大佛药业股份有限公司 一种鲑降钙素鼻喷雾剂及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4786396A (en) * 1995-02-08 1996-08-27 Therapicon S.R.L. Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151276A (en) 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
JPS5885813A (ja) 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
US4900730A (en) 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
GB2092002B (en) * 1981-01-14 1985-09-11 Toyo Jozo Kk Suppositories injectable solutions
US5169849A (en) 1982-02-01 1992-12-08 Sandoz Ltd. Nasal pharmaceutical compositions
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
US4476116A (en) 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
AU572815B2 (en) 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
CH657858A5 (de) 1983-06-27 1986-09-30 Ciba Geigy Ag Substanz aus der gruppe der calcitonine.
JPS61267528A (ja) 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
IT1204400B (it) 1986-06-20 1989-03-01 Sclavo Spa Composizioni farmaceutiche contenente una calcitonina
US5938654A (en) 1987-06-25 1999-08-17 Alza Corporation Osmotic device for delayed delivery of agent
US5059587A (en) * 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
ES2061688T3 (es) 1987-11-13 1994-12-16 Smithkline Beecham Farma Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
US5026825A (en) 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
US5514365A (en) 1988-10-11 1996-05-07 Schiapparelli Salute S.P.A. Pharmaceutical compositions comprising calcitonin for intranasal administration
US5725871A (en) 1989-08-18 1998-03-10 Danbiosyst Uk Limited Drug delivery compositions comprising lysophosphoglycerolipid
IT1231957B (it) 1989-09-15 1992-01-16 Esseti Chimico Farmaco Bio Composizioni farmaceutiche stabili a base di calcitonina.
DE69001991T2 (de) 1989-11-16 1993-09-23 Phidea Spa Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten.
US5733572A (en) 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
AU7880991A (en) 1990-05-10 1991-11-27 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
JPH078806B2 (ja) 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
IT1243390B (it) 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
EP0489217A1 (de) 1990-12-05 1992-06-10 Dr. A. Tosi Farmaceutici S.R.L. Calcitoninzusammensetzungen zur intranasalen Verabreichung
US5234906A (en) 1991-01-10 1993-08-10 Amylin Pharmaceuticals, Inc. Hyperglycemic compositions
IT1254707B (it) 1991-02-19 1995-10-09 Mediator Srl Uso topico della calcitonima per la preparazione di medicamenti nella cataratta idiopatica senile e una composizione farmaceutica che la contiene
GB9108634D0 (en) 1991-04-23 1991-06-12 Ciba Geigy Pharmaceutical compositions
JP3608802B2 (ja) * 1991-09-20 2005-01-12 第一サントリーファーマ株式会社 安定なカルシトニン医薬組成物及びその製造法
US5571788A (en) 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
US5534496A (en) 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US6509006B1 (en) 1992-07-08 2003-01-21 Inhale Therapeutic Systems, Inc. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
US5759566A (en) 1992-07-28 1998-06-02 Poli Industria Chimica Spa Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents
US5654000A (en) 1992-07-28 1997-08-05 Poli Industria Chimica S.P.A. Pharmaceutical compositions for transmucosal delivery of peptides
FR2697022B1 (fr) 1992-10-19 1994-12-16 Pasteur Institut Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
IT1255895B (it) 1992-10-20 1995-11-17 Laura Chiodini Composizioni farmaceutiche contenenti una calcitonina
JP3628713B2 (ja) 1993-06-07 2005-03-16 帝國製薬株式会社 生理学的に活性なペプチドを含有する膣投与製剤
SE9302135D0 (sv) 1993-06-18 1993-06-18 Kabi Pharmacia Ab New pharmaceutical composition
KR950007873A (ko) 1993-09-20 1995-04-15 후꾸하라 요시하루 생리 활성 물질 지속 방출형의 의약 제제
US5496801A (en) 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
EP0803255A4 (de) 1994-06-03 1999-06-30 Tsumura & Co Arzneimittel
US5670163A (en) 1994-06-20 1997-09-23 Kv Pharmaceuticals Company Long acting GI and esophageal protectant
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
US5726154A (en) 1996-06-28 1998-03-10 University Of Utah Research Foundation Stabilization and oral delivery of calcitonin
US6440446B1 (en) 1998-04-22 2002-08-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Agent for anti-osteoporosis
US6153582A (en) 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
US6149893A (en) * 1999-03-01 2000-11-21 Alfa Wassermann S.P.A. Pharmaceutical compositions containing calcitonin in a spray dosing feeder for intranasal administration
WO2001056594A1 (en) 2000-02-04 2001-08-09 Unigene Laboratories, Inc. Nasal calcitonin formulations
US6524580B1 (en) 2000-02-15 2003-02-25 Allergan Sales, Inc. Method for treating thyroid disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4786396A (en) * 1995-02-08 1996-08-27 Therapicon S.R.L. Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin

Also Published As

Publication number Publication date
EP1251867A1 (de) 2002-10-30
AU3660401A (en) 2001-08-14
CA2399505A1 (en) 2001-08-09
CN1183965C (zh) 2005-01-12
US6440392B1 (en) 2002-08-27
CN1422160A (zh) 2003-06-04
CA2399505C (en) 2012-01-03
EP1251867A4 (de) 2004-12-08
USRE40812E1 (en) 2009-06-30
USRE43580E1 (en) 2012-08-14
WO2001056594A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
USRE43580E1 (en) Nasal calcitonin formulations
US5902789A (en) Nasal administration of drugs
ES2274651T3 (es) Formulacion farmaceutica en forma de aerosol para aparte bucal y pulmonar y dispensador de dosis medidas que contiene la misma.
JPH07103043B2 (ja) カルシトニン組成物およびその用途
EP0397447B1 (de) Pharmazeutische Zusammensetzungen
Lee et al. The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer
US8153587B2 (en) Orally administering parathyroid hormone and calcitonin
US5763398A (en) Nasal administration of desmopressin
JPH05508616A (ja) 治療用エアロゾル剤
WO2005004895A2 (en) Compositions and methods for enhanced mucosal delivery of growth hormone
GB2127689A (en) Calcitonin inhalation compositions
US20060067891A1 (en) Metered dose spray device for use with macromolecular pharmaceutical agents such as insulin
US7893025B2 (en) Use of growth hormone releasing factor analogs in treating patients suffering from wasting
US6315984B1 (en) Pressurized container having an aerosolized pharmaceutical composition
US20100256060A1 (en) Peptide pharmaceuticals for nasal delivery
Hanson et al. Intranasal delivery of the peptide, salmon calcitonin
AU2006299887A1 (en) PTH formulations and methods of use
JPS6357527A (ja) 薬剤の吸着防止方法
JPS63243033A (ja) 経鼻投与組成物
IE56602B1 (en) Galenic compositions comprising calcitonin and their use
JPH0525057A (ja) カルシトニンを含有する医薬組成物
KR20080071184A (ko) 경구로 흡수되는 약학적 제형 및 투여 방법
IE56601B1 (en) Galenic compositions comprising calcitonin and their use